DESTINE Health was born out of a research project at the University of Calgary in conjunction with the Calgary Stroke Program. Dr. Jessalyn Holodinsky and Dr. Noreen Kamal spent 3 years researching the best transportation system for patients with large vessel occlusion stroke (one of the most serious types of stroke) to access advanced treatments.
After their innovative solution to the stroke transport problem gained wide international attention in the stroke community Drs. Holodinsky and Kamal decided it was time to take the next step and turn their research into an online interactive software. DESTINE Health was founded in 2018 and since then has helped healthcare systems worldwide transform their stroke transport systems for the better.
Noreen is an engineer and researcher with a specialization in interactive visual analytics and human-computer interaction. She brings years of experience in private industry and over a decade of experience in improving health care systems.
Jessalyn is an epidemiologist specializing in predictive modelling for stroke outcomes. She developed the science behind DESTINE as part of her PhD dissertation. She has since become a sought after speaker in the area of acute ischemic stroke patient transport for local and international conferences.
Deciding on the right strategy for accessing endovascular therapy is a matter of life and limb for ischemic stroke patients. Should stroke patients be taken to a distant endovascular centre or is it best to receive early alteplase at a nearer centre? Selecting the first destination hospital for these patients is complex and depends on geography and hospital efficiency. Every minute you spend thinking about what to do with a stroke patient – the brain is actively dying. There is no time to waste, a decision support tool is needed.
DESTINE allows you to view your stroke system with interactive visualizations; taking complex stroke transport decision making and simplifying it into an easy to read colour coded map. DESTINE’s sophisticated algorithms incorporate the progression of the disease with geographic and health system variables, giving you confidence that your endovascular therapy access strategy is evidence-based. Optimizing your stroke system will lead to significant savings of downstream healthcare costs by maximizing good patient outcomes and getting more patients home to their families.
Professor, Cumming School of Medicine, University of Calgary; Stroke Neurologist, Foothills Medical Centre
Associate Professor Warren Alpert Medical School of Brown University; Director Interventional Radiology
Associate Professor, Warren Alpert Medical School of Brown University; Director Neurovascular Center; Sr Member, Society of NeuroInterventional Surgery
Consultant in Neurology, Karolinska University Hospital; Chair, Swedish Acute Neurology Society
Associate Professor, Cumming School of Medicine, University of Calgary; Stroke Neurologist, Foothills Medical Centre